Want to see DSGN full AI Analyst Report?
Design Therapeutics (DSGN) Ratios
Design Therapeutics Ratios
DSGN's free cash flow for Q2 2026 was $-15.54M. For the 2026 fiscal year, DSGN's free cash flow was decreased by $-21.00K and operating cash flow was $-15.52M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 |
| Quick Ratio | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 |
| Cash Ratio | 1.29 | 2.67 | 2.20 | 2.46 | 56.52 |
| Solvency Ratio | -5.05 | -4.90 | -5.55 | -4.54 | -4.20 |
| Operating Cash Flow Ratio | -4.16 | -5.09 | -6.09 | -4.76 | -5.56 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 210.08M | $ 238.04M | $ 272.63M | $ 321.29M | $ 377.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | 1.04 | 1.04 | 1.04 | 1.02 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.04 | 0.05 | 0.07 | 0.08 |
| Net Debt to EBITDA | 0.22 | 0.41 | 0.27 | 0.36 | 8.26 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 87.83% | 79.49% | 85.51% | 93.66% | 99.17% |
| Return on Assets (ROA) | -30.85% | -19.67% | -23.08% | -18.56% | -9.10% |
| Return on Equity (ROE) | -32.84% | -20.48% | -24.08% | -19.34% | -9.30% |
| Return on Capital Employed (ROCE) | -37.28% | -25.61% | -27.92% | -20.46% | -9.30% |
| Return on Invested Capital (ROIC) | -37.13% | -25.52% | -27.85% | -20.42% | -9.29% |
| Return on Tangible Assets | -30.85% | -19.67% | -23.08% | -18.56% | -9.10% |
| Earnings Yield | -12.98% | -14.20% | -45.07% | -11.08% | -3.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.27 | 0.28 | 0.15 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -1338.74 | -1318.62 | -2369.37 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 1338.74 | 1318.62 | 2369.37 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.95 | -0.76 | -1.05 | -0.92 | -0.64 |
| Free Cash Flow Per Share | -0.95 | -0.77 | -1.05 | -0.94 | -0.67 |
| Dividend Paid and CapEx Coverage Ratio | -281.65 | -126.78 | -228.75 | -55.90 | -19.10 |
| Capital Expenditure Coverage Ratio | -281.65 | -126.78 | -228.75 | -55.90 | -19.10 |
| Operating Cash Flow Coverage Ratio | -35.41 | -18.47 | -19.20 | -13.90 | -8.09 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -10.14% | -12.44% | -39.64% | -9.14% | -3.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.69 | -7.04 | -2.22 | -9.03 | -27.68 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.53 | 1.44 | 0.53 | 1.75 | 2.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.86 | -8.04 | -2.52 | -10.94 | -31.82 |
| Price-to-Operating Cash Flow Ratio | -9.89 | -8.10 | -2.53 | -11.14 | -33.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.20 | 0.27 | -0.51 | -0.19 | -0.18 |
| Enterprise Value Multiple | -7.55 | -6.71 | -1.96 | -8.73 | -19.29 |
| Enterprise Value | 522.44M | 328.91M | 130.21M | 548.75M | 688.64M |
| EV to EBITDA | -7.55 | -6.71 | -1.96 | -8.73 | -19.29 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -9.58 | -7.57 | -2.21 | -10.51 | -22.28 |
| EV to Operating Cash Flow | -9.61 | -7.63 | -2.22 | -10.69 | -23.44 |
| Tangible Book Value Per Share | 3.71 | 4.28 | 4.96 | 5.88 | 8.32 |
| Shareholders’ Equity Per Share | 3.71 | 4.28 | 4.96 | 5.88 | 8.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.78 | 0.87 | 0.88 | 0.81 | 0.83 |
Currency in USD
